Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
- 28 July 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 35 (11), 2143-2154
- https://doi.org/10.1038/npp.2010.105
Abstract
Little is known regarding the mechanisms underlying the complex etiology of mood disorders, represented mainly by major depressive disorder and bipolar disorder. The 1996 discovery that lithium inhibits glycogen synthase kinase-3 (GSK3) raised the possibility that impaired inhibition of GSK3 is associated with mood disorders. This is now supported by evidence from animal biochemical, pharmacological, molecular, and behavioral studies and from human post-mortem brain, peripheral tissue, and genetic studies that are reviewed here. Mood disorders may result in part from impairments in mechanisms controlling the activity of GSK3 or GSK3-regulated functions, and disruptions of these regulating systems at different signaling sites may contribute to the heterogeneity of mood disorders. This substantial evidence supports the conclusion that bolstering the inhibitory control of GSK3 is an important component of the therapeutic actions of drugs used to treat mood disorders and that GSK3 is a valid target for developing new therapeutic interventions.Keywords
This publication has 192 references indexed in Scilit:
- Blocked Inhibitory Serine-Phosphorylation of Glycogen Synthase Kinase-3α/β Impairs In Vivo Neural Precursor Cell ProliferationBiological Psychiatry, 2009
- Disrupted in Schizophrenia 1 Regulates Neuronal Progenitor Proliferation via Modulation of GSK3β/β-Catenin SignalingCell, 2009
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicityCellular Signalling, 2008
- Forkhead Box, Class O Transcription Factors in Brain: Regulation and Behavioral ManifestationBiological Psychiatry, 2008
- Risk for Depression During Interferon-Alpha Treatment Is Affected by the Serotonin Transporter PolymorphismBiological Psychiatry, 2008
- Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediatorsEuropean Journal of Pharmacology, 2008
- Generation and behavioral characterization of β-catenin forebrain-specific conditional knock-out miceBehavioural Brain Research, 2008
- Twenty years of research on cytokine-induced sickness behaviorBrain, Behavior, and Immunity, 2006
- Lithium Regulates Glycogen Synthase Kinase-3β in Human Peripheral Blood Mononuclear Cells: Implication in the Treatment of Bipolar DisorderBiological Psychiatry, 2006